ESR1 and ductal breast carcinoma in situ: Mouse mammary tumor development in the Trp53 null model has many similarities to human breast cancer, including the progression from pre-neoplastic lesions to ductal carcinoma in situ to tumors of diverse histopathology and a subset of the tumors expressing the estrogen receptor (ER+) (19, 20).